Sarepta Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | — | -1,371.2% | -1,391.7% |
| FY2015 | — | -17,572.5% | -17,560.3% |
| FY2016 | 97.6% | -4,920.3% | -4,930.2% |
| FY2017 | — | -111.0% | -32.8% |
| FY2018 | — | -114.1% | -120.2% |
| FY2019 | — | -185.3% | -187.8% |
| FY2020 | — | -104.5% | -102.6% |
| FY2021 | — | -65.5% | -59.7% |
| FY2022 | — | -57.5% | -75.4% |
| FY2023 | — | -21.5% | -43.1% |
| FY2024 | — | 11.5% | 12.4% |
| FY2025 | 98.8% | -31.8% | -32.5% |